Patents Assigned to KBNP, Inc.
  • Attenuated recombinant newcastle disease virus and vaccine containing the same
    Patent number: 8173136
    Abstract: The present invention relates to a recombinant vector for transcription of the Newcastle disease virus (NDV) genome, a strain of attenuated recombinant NDV with a surface antigen of pathogenic NDV prepared by the vector, a method of preparing a recombinant NDV having low pathogenicity and high protectivity efficiency against Newcastle disease (ND) using the vector, and a vaccine against ND containing the recombinant NDV.
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: May 8, 2012
    Assignees: KBNP, Inc., Biopoa, Inc.
    Inventors: Sun-Hee Cho, Hyuk-Joon Kwon, Sun-Joong Kim, Tae-Eun Kim, Young-Jin An, Mi-Joung Ko, Il-Hwan Kim, Young-Ho Park, Chae-Hyun Kim, Jang-Hyuck Han, Tae-Hwan Kim
  • HN epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope
    Patent number: 8029801
    Abstract: The present invention relates to an epitope of HN protein in Newcastle disease virus which can be recognized by an avian immune system and an antibody against the epitope, a method for detecting a Newcastle disease virus by using the antibody, and an antigenic variant of Newcastle disease virus carrying changes in the epitope. The epitope of HN protein and the antigenic variant of Newcastle disease virus can be used for developing efficient vaccines, and further, in diagnosing the Newcastle disease virus rapidly and exactly.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: October 4, 2011
    Assignees: KBNP, Inc., Biopoa, Inc.
    Inventors: Sun-Hee Cho, Hyuk-Joon Kwon, Young-Jin Ahn, Sun-Joong Kim, Young-Ho Park, Chae-Hyun Kim, Tae-Hwan Kim, Tae-Eun Kim
  • ATTENUATED RECOMBINANT NEWCASTLE DISEASE VIRUS AND VACCINE CONTAINING THE SAME
    Publication number: 20100183664
    Abstract: The present invention relates to a recombinant vector for transcription of the Newcastle disease virus (NDV) genome, a strain of attenuated recombinant NDV with a surface antigen of pathogenic NDV prepared by the vector, a method of preparing a recombinant NDV having low pathogenicity and high protectivity efficiency against Newcastle disease (ND) using the vector, and a vaccine against ND containing the recombinant NDV.
    Type: Application
    Filed: September 27, 2006
    Publication date: July 22, 2010
    Applicant: KBNP, Inc.
    Inventors: Sun-Hee Cho, Hyuk-Joon Kwon, Sun-Joong Kim, Tae-Eun Kim, Young-Jin An, Mi-Joung Ko, Il-Hwan Kim, Young-Ho Park, Chae-Hyun Kim, Jang-Hyuck Han, Tae-Hwan Kim